Exelixis
EXEL
#1563
Rank
ยฃ10.45 B
Marketcap
ยฃ42.19
Share price
-0.44%
Change (1 day)
47.67%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company